Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600119912Phase 4Recruiting
Phase 4, randomised trial of remimazolam (2 arms), sponsored by Shouguang Traditional Chinese Medicine Hospital. Primary endpoint: Success rate of anesthesia induction. Started Feb 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600119912.